Fas/CD95 is a critical mediator of cell death in many chronic and acute liver diseases and induces apoptosis in primary hepatocytes in vitro. In contrast, the pro inflammatory cytokine tumor necrosis factor IX (TNFIX) fails to provoke cell death in isolated hepatocytes but has been implicated in hepatocyte apoptosis during liver diseases associated with chronic inflammation. Here we report that TNFIX sensitizes primary murine hepatocytes cultured on collagen to Fas ligand (FasL)-induced apoptosis. This synergism is time-dependent and is specifically mediated by TNFIX. Fas itself is essential for the sensitization, but neither Fas up-regulation nor endogenous FasL is responsible for this effect. Although FasL is shown to induce Bid-independent apoptosis in hepatocytes cultured on collagen, the sensitizing effect of TNFIX is clearly dependent on Bid. Moreover, both cJun N-terminal kinase ONK) activation and Bim, another B cell lymphoma 2 homology domain 3 (BH3)-only protein, are crucial mediators of TN FIX-induced apoptosis sensitization. Bim and Bid activate the mitochondrial amplification loop and induce cytochrome c release, a hallmark of type II apoptosis. The mechanism of TNFIX-induced sensitization is supported by a mathematical model that correctly reproduces the biological findings. Finally, our results are physiologically relevant because TNFIX also sensitizes to agonistic anti-Fas-induced liver damage. Conclusion: Our data suggest that TNFIX can cooperate with FasL to induce hepatocyte apoptosis by activating the BH3-only proteins Bim and Bid. ( HEPATOLOGY 2011;53:282-292) E nhanced apoptosis is critically involved in many acute and chronic liver diseases, and hepatocytes are the main cell type undergoing massive cell death during liver injUiy. This process is regulated by a complex network of soluble and cell-associated apoptotic and inflammatory signals. I It is therefore increasingly important to obtain insight into the mechanistic interplay of these signals to define new therapeutic strategies. In 
the liver, apoptosis is mainly initiated by the death receptor ligands Fas ligand (FasL; CD95L) and tumor necrosis factor a (TNFa). 2 After ligand binding, death receptors recruit the adaptor Fas-associated death domain (FADD) and procaspase-8 to their intracellul ar fa ce, and this form s the death-inducing signaling complex (DISC).3 By this assembly, procaspase-8 is autoprocessed and activated, and it can then trigger two different apoptotic signaling pathways. In so-called rype I cells, such as lymphocytes, active caspase-8 directly cleaves and activates procaspase-3 to induce efficient cell death execution."
In rype II cells, such as hepatocytes, apoptosis induction first requires caspase-8-mediated cleavage of BH3-inreracting domain death agonist (Bid) into its truncated form [truncated Bid (tBid)] . tBid belongs to the subclass of B cel l lymphoma 2 homology domain 3 (BH3)-only B cell lymphoma 2 (Bcl2) family members (e.g., Bcl2-like protein 11 [Bim] , p53-up-regulated modulator of apoptosis (Puma) , and Noxa), which sense apoptoti c stimuli and convey the death signals to B cel l lymphoma 2-associated X protein (Bax) and B cell lymphoma 2 homologo us antago nist/ killer (Bak) activation on mitochondria. Although it is sti ll unclear how this activation occurs,s it has become well accepted that Bax and Bale are essential for mitochondrial membrane permeabilization (MOMP) and the release of apoptogenic factors such as cytochrome c and second mitochondria-derived activator of caspases (Smac)/diablo homolog (Diablo).6 Although cytochrome c activates the apoptotic peptidase activating factor I (APAF-l )/caspase-9 apoptosome, which res ults in effector caspase-3/caspase-7 activation , SmaclDiablo neutralizes the caspase-9 and cas pase-3 inhibitor Xlinked inhibitor of apoptosis protein (XIAP). Recently, XIAP has been shown to determine the rype IIIl FasL signaling switch in hepatocytes and [3-pancreatic celll because a large abundance of XIAP requires neutralization of its caspase-3-inhibiting activiry by rype II signaling to allow effective cell death . S. R FasLlCD95L and its corresponding receptor Fas/ C D9 5 play pivotal roles in the immune system; they induce the death of infected cells and obsolete lymphocytes and thereby protect against autoimmuniry and tumor develo pment.
4 .? Furthermore, Fas is constitutively expressed on the surface of hepatocytes and is important to hepatic health and disease. Mice treated with a lethal dose of agonistic anti-Fas antibody die because of mass ive hepatocyte apoptosis and liver failure. l o This cell death is dependent on Bid because Bid-deficient mice are res istant to Fas-induced hepatocellular apoptosis, fulminant hepatitis, and subsequent liver failure. I I
These findings indicate that in vivo hepatocytes die in response to FasL via the rype n signaling p athway?
However, we have shown recently that isolated primary hepatocytes cultured on collagen change their apoptosis signaling from rype II to the Bid-independent type I pathway,1 2 and this suggests that the rype JIll decision depends not only on the expression of endogenous proteins, such as XIAp, but also on external factors. TNFa is a pleiotropic cytokine that induces a variery of cellular responses, such as inflammation and cel l proliferation, mainly through activation of the nucl ear factor kappa B (N F-ICB) signaling cascade. Unlike FasL, the association of TNFa with its main receptor tumor necrosis factor receptor I (TNFRl) does not primarily lead to cel l death in most cel l rypes, including hepatocytes . 13 After activation of TNFRl , m embrane-bound comp lex I is first formed and rapidly activates survival transcription factor NF_KB .14 To signal for cell death, a second comp lex, receptor-free complex II, has to assem ble in the cytoplasm and recruits FADD and caspase-8 to activate caspase-3/caspase-7. 11 Under normal conditions, complex II formation is blocked by cellular Fas-associating protein with death domain-like interleukjn-l beta-converting enzyme (FLICE) inhibitory protein (c-FLIP) and NF-ICB sur-
VIV signa mg. ' owever, t IS reg anon can e circumvented by yet ano ther TNFa-activated apoptotic signaling pathway that involves activation of c-J un Nterminal kinase ONK). It has been shown that JNK mediates TNFa-induced apoptotic signaling by the phosphorylation and activation of the BH3-only protein Bim. U. 17 In agreement with this notion , TNFo:-induced hepatocyte apoptosis has recently been reported to require both Bim and Bid in vivo. I R In this study, active caspase-8 generated tBid, w hereas active JNK phosphorylated a nd stabilized Bim, and the interplay of both processes was necessary to induce ful l Bax/Bak activation and hepatocyte apoptosis in response to TNFa .
H ere we show that a simil ar Bim/Bid interplay is used by TNFa to sensitize primary mouse hepatocytes to FasL-induced apoptos is in vitro. We also demonstrate this sensitizing effect toward anti-Fas-induced liver damage in vivo. Although TNFa itself is nonapoptotic, it markedly enhances FasL-induced hepatocyte apoptosis via both the JNK/Bim and Bid signaling pathways. These data co nfirm that TNFa is capable not on ly of engaging the JNK/Bim apoptotic pathway but also of restoring type II signaling on co llagen-cultured primary hepatocytes. This crosstalk is supported by a systems bio logy approach because we present a qualitative mathematical model that correctly reproduces the biological findings. 
Materials and Methods

Isolation and Cultivation of Primary
Results
TNFrJ. Preincubation of Primary Mouse Hepatocytes Increases FasL-Induced Caspase-3 Activation and Cell Death in a Time-Dependent Manner
We previously repo rted that FasL induces the apoptosis of collagen-cultured primary murine hepatocytes via the type I signaling pathway, but only to a moderate extent. 12 In this study, we focused on the crosstalk of FasL with the proinflammatory cytokine TNFex. We preincubated collage n-cultured primary murine hepatocytes with 25 ng/mL TNFa for 12 hours, and this was followed by a treatment with 50 ng/mL FasL for 6 hours. As expected, untreated and TNFa-treated hepatocytes showed a typical binucl ear morphology and no signs of cel l death over an incubation period of 18 hours (Fig. 1A) . In contrast, as previously reported, cells treated with FasL for 6 hours showed hallmarks of apo ptosis such as cell shrinkage and plas ma membrane blebbing.
12 When the cells were preincubated with TNFa for 12 hours before the FasL treatment, they underwent a significantly higher degree of apoptosis (Fig. lA) . T hese findings cou ld be confirmed by the measurement of the effecto r caspase-3 /caspase-7 activity in response to the different treatments. As shown in Fig. lB , the longe r the hepatocytes were cu ltured (J 2, 24, or 48 hours), the more caspase-3/caspase-7 activity they displayed with a 6-hour FasL treatment. If during this culturing the cells were exposed to TNFa, the caspase-3/caspase-7 activities further increased and were consisten tly higher than those with FasL alone. Importantly, a minimum preincubation time of-approximately 2.5 to 3 hours was needed for TNFa to exert its sensitization on FasL-induced caspase-3/caspase-7 activation , and this indicated that the TN Fa effect was not immediate (Fig. 1 C) . We also tested the dose dependence of the sensitization and found that varying the TNFa concentrations from 10 to 50 ng/mL did not modulate the preincubation time required for sensitization (Supporting Fig. 2 ). Moreover, the sensitization was clearly caspase-dependent because cell death (as 
Sensitization of FasL-Induced Apoptosis by TNF(X Is Specific for TNFrr. and the Opposite Sensitization
Cannot Be Observed. Because other factors in the growth medi um may modulate FasL-induced apoptosis signaling, we first co nfirmed that the sensitizing effect is specifically mediated by TNFcx. We therefore added TNFIX-neutralizing antibodies produced by the VI q hybridoma cell line (J 00 J1L of the cu lture supernatant) to the primary hepatocytes 30 minutes before TNFIX and FasL stim ulation . TNFIX-neutralizing antibodies effectively prevented the se nsitization because caspase-3/caspase-7 activity did not increase beyond that measured with FasL alone ( Fig. 2A) . We then tested the inverse scenario (i .e., whether FasL was also able to sensitize hepatocytes to TNFIX-induced apoptosis). For that purpose, cells were first treated with FasL, and 2 hours later, TNFIX was added for a total of 4 hours before th e measurement of active caspase-31 caspase-7. As demonstrated in Fig. 2B , FasL-induced caspase-3/caspase-7 activity could not be further increased by TNFcx. Th is finding co nfirms that the apoptosis sensitization effect of TNFIX is specific for this cytokine, needs a certain time thresho ld (as shown in Fig. 1 C) , and involves a molecular mechanism that cannot be engaged by FasL. To completely exclude the implication of growth factors, we tested the role of fetal bovine serum (FBS) in the sensitization effect. As shown in Supporting Fig. 4 , FBS neither en hanced nor inhibited the sensitization of FasL-induced apoptosis by TNF~ but primary hepatocytes turned out to be more sensitive toward FasL-induced apoptosis in the presence of FBS (see also Walter et aI.
12
). apoptosis required Fas. Therefore, we next tested whether sensitization could be due to up-regulation of endogenous Fas by TNFct However, the qRT-PCR analys is did not reveal any induction of Fas messe nger RNA (mRNA) in response to TNFC( (data no t shown). Besides Fas, TNFC( could up-regul ate endogenous FasL and thereby am pli fY the FasL-induced apoptotic respo nse. To test this hypothesis, we analyzed TNFC( sensitization in
TNF(X Sensitization Is Not Mediated via Transcriptional Up-Regulation of Fas
as " epatocytes, w I C 1 express a mutant rorm 0 FasL that canno t bind Fas. As shown in Fig. 3B , the loss of endogenous FasL production did not significan t1 y reduce the enhanced caspase-3/ caspase-7 activation because of TNFC( preincubatio n of the FasL-treated cells. T hese findings indicate that TNFC( impinges on the intracel lular FasL signali ng pathway rather than the regulation of Fas or FasL in order to sensitize primary hepatocytes to FasL-induced apoptosis.
Bid but Not XIAP Is Critical for TNFrx Sensitization. Because our findings so fa r suggested direct crosstalk between TNFC( and Fas signaling, we performed a detailed analys is of the components of the twO signaling pathways. We recently reported that FasL-induced apoptosis of co ll age n-cultured primary . mouse hepatocytes occurred independently of Bid. T his was in contrast to apoptosis induced by TNFC(/ ActO, which still required Bid (type II signaling). 12 We therefore tested whether this was also the case for the sensitization effect of TNFC( on FasL-induced apoptosis. Indeed, altho ugh Bid-I -hepatocytes showed the same caspase-3/caspase-7 activation in response to FasL that WT cells showed, the increased caspase-3/caspase-7 activation due to treatment with T NFC( and FasL was entirely abolished (Fig. 4A) . Both cell death (based on the MIT assay; Supporting Fig. 5A ) and apoptosis-associated DNA fragmentation (Supporting Fig. 5B increased expression of the Bid protein (Fig. 4B) and mRNA ( Fig. 4C) and this further strengthened a crucial role of this protein in the sensitizing mechanism. Bid processing was also observed with FasL alone, but this did not contribute to apoptosis induction (Fig. 4A) . Thus, our results show that although Bid is not required for FasL-induced apoptosis on collagen-cul-287 tured hepatocytes, it is absolutely crucial for the TNFa sensitization of this process.
XlAP is an endogenous inhibitor of caspase-9 and effector caspase-3/caspase-7 and restrains apoptosis along the type I pathway unless it is neutralized by apoptogenic factors emanating from mitochondria. Accordingly, as we previously showed , XlAP -/-hepatocytes exhibited 10-fold higher caspase-3/caspase-7 activity in response to FasL than WT cells (Supporting Fig. 6 ). T his activity was not further increased by TNFa preincubation. However, a slight sensitization was seen at low FasL doses (10-20 ng/mL) . This indicates that deletion of XlAP does not abrogate the TNFa sensitization to FasL-induced apoptosis. Importantly, XlAP protein (Supporting Fig. 7 ) and mRNA (Supporting Fig. 16C ) remained nearly unchanged during TNFa preincubation. Thus, XlAP turned out to be dispensable for the sensitizing effect of TNFa.
TNF(J. Activates JNK, and JNK Inhibition Blocks
Apoptosis Sensitization by TNFa. Activation of JNK has been implicated in TNFa-induced apoptosis in several cell types, including hepatocytes. 19,20 We therefore monitored the active phosphorylated form of JNK by anti-phospho-JNK western blot analysis in primary mouse hepatocytes treated with TNFa. TNFa/ActD, which is known to induce apoptosis by prolonged JNK activation,21 was included as a positive control. We found that TNFa induced early phosphorylation of JNK in the first 30 minutes, although this was not as high as that with TNFa/ ActD after 6 or 8 hours (Fig.  5A) . To investigate the significance of this early JNK activation for apoptosis sensitization, we preincubated primary hepatocytes with the JNK inhibitor anthra[1-9-cdJpyrazol-6(2H) -one (SP600125; 25{IM), which was followed by FasL or a consecutive treatment with TNFa and FasL. Strikingly, JNK inhibition could effectively block the sensitizing effect of TNFa on caspase-3/caspase-7 activation because DEVDase activity levels in the presence of SP600 125, TNFa, and FasL were essentially the same as those with FasL alone (Fig, 5B) , This decrease in caspase-3/caspase-7 activity resulted in a significant reduction in actual cell death and apoptosis (Supporting Fig, 8 ), and this supported the role of JNK in the sensitization, In contrast, the p38 mitogen-activated protein kinase inhibitor RN3503 (10 {1M) had no effect ( Supporting Fig, 9 ), and this indicated that JNK (but not p38 mitogen-activated protein kinase) was crucially involved in apoptosis sensitization by TNFa. Fig, lA) and western blot analysis (Supporting Fig.  1 B) , respectively, Strikingly, although control siRNA did not affect caspase-3/caspase-7 activity levels in cells treated with TNFa and FasL, siBim significantly reduced them to the levels measured with FasL alone (Fig. 5C ). In addition, the loss of Bim resulted in decreased apoptosis"associated DNA fragmentation and cytotoxicity upon treatment with TNFa and FasL (Supporting Fig, 10 ). Thus, both Bid and Bim seem to be required for the sensitization effect of TNFa on the FasL-induced apoptosis of primary mouse hepatocytes. Because JNK is also crucial for this effect and the inhibition of JNK could not abrogate tBid formation (Fig. 4B) , we suggest that the implication of Bim involves its JNK-mediated phosphorylation, as previ- 
Bim Is Essential for the Sensitizing Effect of
TNFrx Sensitization Involves Restoration of TYpe II Signaling in Collagen-Cultured Hepatocytes. Both
Bid and Bim relay apoptotic signals to the activation of Bax/Bak, which in turn triggers MOMP and the release of cytochrome c and other apoptogenic factors (type II signaling). We therefore tested whether TNFa-mediated sensitization to FasL-induced apoptosis involved cytochrome c release. For that purpose, we prepared cytosolic and mitochondrial fractions from TNFatreated, FasL-treated, or TNFalFasL-treated hepatocytes, verified their purity by western blot analysis (Supporting Fig. 11) , and determined the concentration of cytosolic 
TNFa+Jo2
A cytochrome c by ELISA. As shown in Fig. 6 , cytochrome c could indeed be detected in the cytosol of hepatocytes treated with TNFIX and FasL, whereas neither TNFIX nor FasL alone promoted any cytochrome c release, as previously described.
12 Importantly, cytochrome c release did not occur in TNFIX/FasL-treated Bid-I -hepatocytes or when JNK was inhibited (Fig. 6) , and this supported the notion that Bid and JNK were involved in the sensitization mechanism. These results indicate that TNFIX enhances FasL-induced apoptosis of collagen-CLutured primary hepatocytes by activating a Bid-dependent and Bim-dependent type II apoptosis pathway. We also investigated whether antiapoptotic Bel2 family members were modulated during TNFIX sensitization, but neither B cell lymphoma extra large (Bel-XL) nor myeloid cell leukemia sequence 1 (Mel-I) levels were up-regulated or downregulated (Supporting Fig. 12 ). observed in vivo, mice were injected with recombinant murine TNFIX followed by anti-Fas antibody 002), and liver damage was assessed by the measurement of AST levels . Strikingly, these first experiments revealed an increase in AST levels (Fig. 7 A) and tissue damage, which was shown by an enhancement of apoptotic cells (Fig. 7B ) when mice were challenged with TNFIX and J02 versus J02 administration alone. Before final concl usions can be drawn, further experiments have to be performed. Nevertheless, these results indicate that the sensitizing effect reported here could be physiologically and clinically relevant. Figs. 13 and 14) . In Fig. 8E , the simulation results for caspase-3 activation are compared to the respective measurements for WT and XlAP -I-and Bid -I -hepatocytes. Overall, the model is able to accurately reproduce the observed sensitizing effect in all studied genorypes.
TNF(I. Sensitizes Mice
Mathematical Modeling Confirms the Mechanism
Discussion
TNFa is a proinflammatory cytokine that plays a crucial ro le in both liver regeneration 24 25 In this respect, we analyzed some ryp ical anti apoptotic NF-KB target genes such as cellular inhibitor of apoptosis 2 (cIAP2), c-FLIp, and XlAl~ but we found that they were only moderately up-regulated (if ever) in response to TNFa (see Supporting Fig. 16 ). clAPl protein was not at all detected in hepatocytes (see also Walter et aI.
12
; data not shown). On the other hand, several studies have indicated that TNFa positively regulates Fas-mediated apoptosis. In one case, TNFa could even overcome the Fas resistance of human lung fi broblasts 2G by allowing more FADD adaptor to bind to Fas and therefore increase DISC formation and FasLmediated apoptotic signaling. In contrast to human lung fibroblasts, primary mouse hepatocytes do not seem to have impaired DISC formation because they are quite sensitive to FasL-induced apoptosis.
To obtain evidence for the physiological relevance of TNFa/FasL crosstalk, Costelli et al. 27 findings have been observed for TNF-related apoptosisinducing ligand (TRAIL), which enhances Fas-induced hepatocyte apoptosis and liver damage via activation of the JNK-Bim axis 23 ; this suggests some ove rlapping effects of different TNF family members. Our results with cultured primary mutine hepatocytes support the aforementioned mechanism. TNFa preincubation led to JNK activation, and the inhibition of JNK and the loss of Bim abolished the sensitizing effect; however, FasLinduced apoptosis remained unchanged. In addition, sensitization was mitigated by the loss of Bid. In our study, TNFa needs to crosstalk with Fas to exert its apoptosissensitizing effect. We recently reported the unexpected finding that in collagen-cultured primary mouse hepatocytes, Fas signaling switches from a rype II, Bid-dependent apoptotic signaling pathway to a rype I, Bidindependent apoptotic signaling pathway. As shown here, TN Fa is obviously able to restore the rype II signaling pathway by a so far unknown m echanism. It wi ll be cruci al to identifY these crosstalk points between TNFa and FasL signaling. Our data suggest that Bim and Bid may be part of these points. Both act by trigge ring Bax/Bak-mediated MOMP and cytochrome c release, but perhaps this occurs efficiently only when both are indeed present and activated. TNFa would activate Bim via JNK and regulate Bid in a so far unknown way such that it becomes required for FasL-induced apoptosis. This would explain why TNFa-induced sensitization is impeded in both Bim knockdown and Bim -/-hepatocytes. We therefore suggest that Bim and Bid can only cooperatively activate the mitochondrial amplification loop in hepatocytes and that this is crucial for the observed increased sensitiviry to FasL-induced apoptosis.
T he presented mathematical model accurately reproduces the sensitizing effect and will promote further directions for future research. Sensitivity analysis reveals the sensitizing mechanisms to be very robust, although the model contains only the most important players. Most critical interactions for the crosstalk model after TNFa and FasL stimulation are the ones associated with Bid and also all reactions associated with Bim (see the supporting information for the model equations). XIAP has a prominent role as a caspase-3 buffer, and the function of Bel2 family members has turned out to be essential for the model because the sensitizing effect is completely disrupted otherwise (Supporting Fig. 15 ) . Consequently, it would be of special interest to further analyze the specific function and interplay of pBim and other members of the Bel2 fami ly.
Because many chronic liver diseases in which FasL levels are elevated are associated with chronic inflammation, the herein reported TNF/FasL crosstalk might be of clinical relevance. Our first in vivo studies showing TNFex sensitization toward anti-Fas-induced li ver damage strengthen this ass umption. Elevated T N F levels due to inflammatory processes might affect many acute and ch ro nic live r diseases by enhancing FasL-induced apoptosis signaling and, therefore, might constitute a poss ibl e therapeutic target.
